CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Vivoryon Therapeutics AG Company Snapshot
Vivoryon Therapeutics AG operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vivoryon Therapeutics AG with three other miscellaneous service companies in Europe: Immunicum AB of SWEDEN (2012 sales of 5,000.00 Swedish Kronor [US$519.80 ] of which 100% was Biopharmaceutical), Nordic Nanovector Asa of NORWAY (148,145.00 Norwegian Kroner [US$14,975.98 ] ), and Serodus Asa which is also based in NORWAY (51,600.00 Norwegian Kroner [US$5,216.24 ] ).

Sales Analysis.
   
   
 
  Stock Performance Chart for Vivoryon Therapeutics AG
 
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 3.85
(Figures in Euros )
1 Week 3.4%   13 Weeks -11.9%  
4 Weeks -33.5%   52 Weeks -26.3%  
 
Vivoryon Therapeutics AG Key Data:
  Ticker: VVY Country: Germany
  Exchanges: AMS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2012 Sales 6,000
(Year Ending Jan 2013).
Employees: 16
  Currency: Euros Market Cap: 76,905,606
  Fiscal Yr Ends: December Shares Outstanding: 19,975,482
  Share Type: Stammaktie Closely Held Shares: 6,328,803
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.